To study whether there is a relationship between Apollon expression and chemotherapeutic response in ESCC patients, we analyzed another cohort of 70 ESCC patients who had undergone cisplatin-based chemotherapy. Here, BIRC6 is linked to esophageal squamous cell carcinoma.